Trending News

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights
Posted On Thursday, May 01, 2025
Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy
Posted On Thursday, May 01, 2025
Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations
Posted On Thursday, May 01, 2025
NextCure Provides Business Update and Reports First Quarter 2025 Financial Results
Posted On Thursday, May 01, 2025
Sutro Biopharma to Participate in Upcoming Investor Conferences
Posted On Thursday, May 01, 2025
89bio Reports First Quarter 2025 Financial Results and Corporate Updates
Posted On Thursday, May 01, 2025
Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
Posted On Thursday, May 01, 2025
Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements
Posted On Thursday, May 01, 2025
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference
Posted On Thursday, May 01, 2025
Kura Oncology Reports First Quarter 2025 Financial Results
Posted On Thursday, May 01, 2025
Aura Biosciences to Participate in Upcoming Investor Conferences
Posted On Thursday, May 01, 2025
Ascendis Pharma Reports First Quarter 2025 Financial Results
Posted On Thursday, May 01, 2025
scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences
Posted On Thursday, May 01, 2025
Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update
Posted On Thursday, May 01, 2025
Eascra Biotech Expands Operations with a New Worcester Lab
Posted On Thursday, May 01, 2025
Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates
Posted On Thursday, May 01, 2025
Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
Posted On Thursday, May 01, 2025
BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting
Posted On Thursday, May 01, 2025
Enara Bio Strengthens Senior Leadership with Key Executive and Board Appointments Alongside Acceleration of Multiple T-Cell Engager Programs
Posted On Thursday, May 01, 2025
OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-902, a Trop-2 Targeting ADC
Posted On Wednesday, April 30, 2025
Nxera Pharma’s Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia
Posted On Wednesday, April 30, 2025
Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
Posted On Wednesday, April 30, 2025
Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations
Posted On Wednesday, April 30, 2025
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
Posted On Wednesday, April 30, 2025
Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025
Posted On Wednesday, April 30, 2025

Print